Cell-line platform
Our cell-line platform operates with a wide range of cell systems, including established cell lines, primary cells and iPSCs. Collaborating with our advanced technology platforms, we offer off-the-shelf solutions like reporter cell lines and 2D single-cell cultures. Additionally, we develop complex co-cultures and organoids as disease-relevant human translational cell systems.
LEARN MORE
High-throughput assay systems
To monitor cellular phenotypic drug responses, Nuvisan’s state-of-the-art infrastructure supports the development of classical end-point assays, kinetic readouts in living cells, high-content assays, Meso Scale Discovery (MSD), precision protein analysis, and multiparametric flow cytometry and FACS. Our next-generation sequencing (NGS) and single-cell sequencing services offer mode-of-action analysis at excellent resolutions.
LEARN MORE
Advanced cellular assays
Our team provides specialised assays and collaborative support to refine hit lists, optimise leads and enhance your understanding of compound behaviour through comprehensive off-target, species selectivity, cell-based, biophysical and biochemical analyses.
LEARN MORE
Human induced pluripotent stem cells
Using patient-derived or gene-edited human iPSCs enables advanced study of human disease. They preserve the donor’s genetic profile and closely resemble actual human cells, making them crucial for current drug development processes.
LEARN MORE
Primary cell assays
To reduce development risks and enhance success rates, we prioritise the translational value of models early on. Primary cells or tissues from human donors and animals are essential components of our drug discovery and profiling efforts.
LEARN MORE
Functional and mechanistic assays
Understanding disease mechanisms is vital, and our mode-of-action assays provide precise research tools. Explore our extensive range of cell-based functional and mechanistic assays that support your drug discovery projects.
LEARN MORE
Immunology platform
This platform offers advanced immunoassays and inflammation models to support your immunology research and development projects across various therapeutic areas, including oncology, inflammation, cardiology, neurology, obesity, diabetes women’s health and metabolic disorders.
LEARN MORE
Technology platforms
Our expertise in disease and target biology, supported by advanced technology platforms, enhances drug discovery across all indications. We monitor functional readouts and provide high-resolution mode-of-action analysis using cutting-edge sequencing services.
LEARN MORE